Esophageal Acidification During Nocturnal Acid-breakthrough with Ilaprazole Versus Omeprazole in Gastroesophageal Reflux Disease

BACKGROUND/AIMS: Though nocturnal acid-breakthrough (NAB) is common in gastroesophageal reflux disease (GERD) patients, its clinical importance results from esophageal acidification, which has been shown to be uncommon. Ilaprazole, a long-acting proton pump inhibitor, may cause NAB infrequently. Acc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurogastroenterol Motil
Main Authors: Karyampudi, Arun, Ghoshal, Uday C, Singh, Rajan, Verma, Abhai, Misra, Asha, Saraswat, Vivek A
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Society of Neurogastroenterology and Motility 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5383115/
https://ncbi.nlm.nih.gov/pubmed/27585842
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5056/jnm16087
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados